Literature DB >> 7542883

Inhibition of tumor necrosis factor alpha- and ceramide-induced internucleosomal DNA fragmentation by herbimycin A in U937 cells.

L Ji1, G Zhang, Y Hirabayashi.   

Abstract

In many tumor cell lines, tumor necrosis factor alpha (TNF alpha) causes apoptosis with characteristic internucleosomal DNA fragmentation. However, the mechanism is largely unknown. Here we examined the involvement of protein tyrosine kinases by using their inhibitors. Among various tyrosine kinase inhibitors tested, only herbimycin A was found to inhibit internucleosomal DNA fragmentation but not apoptotic morphological changes and cell death induced by TNF alpha in U937 cells. Herbimycin A was able to block DNA fragmentation when it was added to the cell culture as late as 1.5 h after TNF alpha treatment. These results demonstrate that herbimycin A selectively inhibits a later event involved in the process of apoptois that results in internucleosomal DNA fragmentation. Sphingomyelinase and ceramide (Cer) induced internucleosomal DNA fragmentation was also inhibited by herbimycin A, supporting the hypothesis that Cer may be a novel second messenger mediating the cytotoxic effect of TNF alpha.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542883     DOI: 10.1006/bbrc.1995.2017

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Butyric acid-induced apoptosis of murine thymocytes, splenic T cells, and human Jurkat T cells.

Authors:  T Kurita-Ochiai; K Fukushima; K Ochiai
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

2.  Tyrphostins reduce chemotherapy-induced intestinal injury in mice: assessment by a biochemical assay.

Authors:  Y Zlotnik; M Patya; A Vanichkin; A Novogrodsky
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

3.  STAT3 regulates inflammatory cytokine production downstream of TNFR1 by inducing expression of TNFAIP3/A20.

Authors:  Ricardo J Antonia; Eveliina Karelehto; Kan Toriguchi; Mary Matli; Robert S Warren; Lawrence M Pfeffer; David B Donner
Journal:  J Cell Mol Med       Date:  2022-07-16       Impact factor: 5.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.